SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-21-000018
Filing Date
2021-02-09
Accepted
2021-02-09 09:41:08
Documents
57
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20201231.htm   iXBRL 10-Q 1441413
2 EX-31.1 a123120exhibit311.htm EX-31.1 10489
3 EX-31.2 a123120exhibit312.htm EX-31.2 10553
4 EX-32.1 a123120exhibit321.htm EX-32.1 5996
5 EX-32.2 a123120exhibit322.htm EX-32.2 5928
11 GRAPHIC siox-20201231_g1.jpg GRAPHIC 67721
  Complete submission text file 0001636050-21-000018.txt   5108122

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20201231.xsd EX-101.SCH 34461
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20201231_cal.xml EX-101.CAL 54008
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20201231_def.xml EX-101.DEF 200869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20201231_lab.xml EX-101.LAB 429012
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20201231_pre.xml EX-101.PRE 286846
12 EXTRACTED XBRL INSTANCE DOCUMENT siox-20201231_htm.xml XML 517972
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 21604244
SIC: 2834 Pharmaceutical Preparations